Literature DB >> 1388210

Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

H A Brady1, A Scaria, W S Wold.   

Abstract

The E3 complex transcription unit of adenovirus encodes four major mRNAs (a, c, f, and h) and two minor (d and e) mRNAs with overlapping exons, alternative splice sites, and two polyadenylation sites, termed E3A (upstream) and E3B (downstream). mRNAs a and d use the E3A polyadenylation site, and mRNAs c, e, f, and h use the E3B site. We have analyzed virus mutants with deletions throughout the E3 region in order to identify cis-acting sequences that function in E3 pre-mRNA processing. The results presented in this report as well as previous results are summarized as follows. (i) Deletions in the first (5') intron at nucleotides (nt) 372 to 768 in E3 had no effect unless they removed the consensus sequence for the nt 372 5' splice site; however, the overall pattern of E3 mRNAs did not change significantly. (ii) Deletions in region I (nt 1441 to 2044) eliminated mRNAs a and c and resulted in corresponding increases in mRNAs f and h; we propose that region I contains sequences that suppress splicing. (iii) Mutations in region II (nt 2161 to 2243) resulted in nearly exclusive synthesis of mRNA f; this phenotype is understood and is discussed. (iv) Changing the AUUAAA component of the E3A poly(A) addition signal to AAUAAA resulted in increased mRNA a levels, suggesting that the E3A poly(A) addition signal is intrinsically inefficient. (v) Deletions in region III (nt 2488 to 3002) decreased mRNA a levels about two- to threefold and specifically increased mRNA f levels; we suggest that region III facilitates use of the E3A polyadenylation site. (vi) Deletions in region IV (nt 2904 to 3251) increased mRNA a levels about two- to threefold; we suggest that region IV may contain sequences that facilitate use of the E3B polyadenylation site. A map of sequences that determine alternative pre-mRNA processing in region E3 is now nearly complete.

Mesh:

Substances:

Year:  1992        PMID: 1388210      PMCID: PMC241468     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor.

Authors:  L R Gooding; L W Elmore; A E Tollefson; H A Brady; W S Wold
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

Review 2.  Poly(A) signals.

Authors:  N Proudfoot
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

3.  Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.

Authors:  M T McNally; R R Gontarek; K Beemon
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

5.  In vivo splicing of the premRNAs from early region 3 of adenovirus-2: association of precursors, intermediates and products with hnRNP.

Authors:  H Gallinaro; A Sittler; M Jacob
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

6.  A 12,500 MW protein is coded by region E3 of adenovirus.

Authors:  L K Hawkins; W S Wold
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

7.  Virus deletion mutants that affect a 3' splice site in the E3 transcription unit of adenovirus 2.

Authors:  B M Bhat; H A Brady; W S Wold
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

8.  Polyadenylic acid addition sites in the adenovirus type 2 major late transcription unit.

Authors:  J M Le Moullec; G Akusjärvi; P Stålhandske; U Pettersson; B Chambraud; P Gilardi; M Nasri; M Perricaudet
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

9.  Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.

Authors:  M T McNally; K Beemon
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2.

Authors:  W S Wold; C Cladaras; S C Magie; N Yacoub
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  10 in total

1.  Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.

Authors:  Alexander R Moise; Jason R Grant; Timothy Z Vitalis; Wilfred A Jefferies
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Identification of a new human adenovirus protein encoded by a novel late l-strand transcription unit.

Authors:  Ann E Tollefson; Baoling Ying; Konstantin Doronin; Peter D Sidor; William S M Wold
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

4.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.

Authors:  J Shisler; C Yang; B Walter; C F Ware; L R Gooding
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.

Authors:  P Krajcsi; T Dimitrov; T W Hermiston; A E Tollefson; T S Ranheim; S B Vande Pol; A H Stephenson; W S Wold
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.

Authors:  A E Tollefson; K Toth; K Doronin; M Kuppuswamy; O A Doronina; D L Lichtenstein; T W Hermiston; C A Smith; W S Wold
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon.

Authors:  P Flomenberg; V Piaskowski; R L Truitt; J T Casper
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Biographical Feature: William S. M. Wold, Ph.D., 1944-2021.

Authors:  Karoly Toth; Ann E Tollefson; G Chinnadurai; Clifford J Bellone; Duane P Grandgenett; Lynda A Morrison; John E Tavis
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

9.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.

Authors:  T W Hermiston; R A Tripp; T Sparer; L R Gooding; W S Wold
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.